[Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D009540:Nicotinyl Alcohol / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011746:Pyrithioxin / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D011725:Pyridines; D009540:Nicotinyl Alcohol; D011746:Pyrithioxin
Klinische Prüfung von Danaden retard bei Funktionspsychosen im Sinne leichter bis mittelschwerer Durch-gangssyndrome